TMS is a strong, selective and competitive inhibitor of cytochrome P450 1B1, an overexpressed enzyme in particular tumors (IC50 = 6 nM). 50- and 520-fold selective over P450 1A1 and 1A2 respectively. TMS inhibits cancer cell growth in vitro.
1. Nam, K.A., et al. 2001. Arch. Pharm. Res. 24: 441-445.
2. Chun, Y.J., et al. 2001. Cancer Res. 61: 8164-8170.
3. Kim, S., et al. 2002. J. Med. Chem. 45: 160-164.